- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
The Summit was attended by Industry representatives (Italy & India), Drug Regulators across from European Continent &...
Read More
Read More
Dr Gurpreet Sandhu (Managing Director) REVA PHARMA was member of the India Delegation which visited HQ of Meiji Seika...
Read More
Read More
APIs forms the most vital part of every formulated end product, and of the whole pharma industry. The overall API market...
Read More
Read More
Indian generics firms see opportunities in the Japanese drug market according to a trade delegation that visited Tokyo...
Read More
Read More
Japanese drug firms eyeing international investments should not be put off by Daiichi Sankyo’s turbulent...
Read More
Read More
CPhI-Japan was inaugurated in a grand style as all the key representatives partner associations of UBM were called on...
Read More
Read More
A strong delegation of major Indian pharmaceutical companies led by Pharmaceutical Export Promotion Council of India...
Read More
Read More